A recent report has shed light on the concerning disparity between legal and illegal drug trials in hospitals in India. According to the report, SVP Hospital in Ahmedabad has conducted only 21 legal drug trials, while VS Hospital has carried out 58 illegal trials. This revelation has raised questions about the safety and ethical practices surrounding drug trials in the country. The findings have sparked a debate among healthcare professionals and policymakers about the need for stricter regulations and oversight in the pharmaceutical industry. Drug trials play a crucial role in testing the safety and efficacy of new medications before they are approved for public use. However, the prevalence of illegal trials raises serious concerns about the potential risks faced by participants and the reliability of the results. It is essential for hospitals and regulatory authorities to work together to ensure that all drug trials are conducted in accordance with established guidelines and ethical standards. The report has highlighted the urgent need for greater transparency and accountability in the drug trial process to protect the health and well-being of patients. This issue underscores the importance of upholding ethical practices in medical research and ensuring the safety of participants in drug trials.